Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Producer : inconnu
  • Date : This year
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Genital diseases (1)
    • Plus ...
      • Female genital diseases (1)
    • Pregnancy and reproduction (1)
    • Plus ...
      • Pregnancy (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Radiotherapy and physical agents (1)
    • Interventional imaging (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Practice guidelines (1)
Date
  • This year (2)
Manufacturer
  • inconnu (2)
  • industriels (1)
Language
  • Français (2)
Active substance
  • amoxicilline (1)
  • fentanyl (2)
  • fer (1)
  • gadolinium (1)
  • misoprostol (2)
  • oxytocine (1)
  • rifamycine (1)
  • sufentanil (1)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Normal childbirth: support of physiology and medical interventions

    Practice guidelines - Posted on 25/1/2018 - Mis à jour le 27/11/2023
    Download abstract
    Add to my selection

Drugs, devices and medical acts - 1 result

  • Evaluation of high-intensity focused ultrasound (HIFU) for the treatment of symptomatic uterine fibroids Brief INAHTA

    Health technology assessment - Posted on 24/7/2024 - Mis à jour le 24/7/2024
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
j8CBbh5eVQXR7whT